Pulmonary Hypertension: Good Intentions, But a Questionable Approach
Ann Am Thorac Soc
.
2018 Jun;15(6):664-666.
doi: 10.1513/AnnalsATS.201803-197ED.
Authors
Peter J Leary
1
,
Bradley A Maron
2
3
4
,
Ryan J Tedford
5
,
Tim Lahm
6
7
Affiliations
1
1 Department of Medicine, University of Washington, Seattle, Washington.
2
2 Department of Cardiology, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.
3
3 Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts.
4
4 Harvard Medical School, Boston, Massachusetts.
5
5 Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
6
6 Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana; and.
7
7 Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
PMID:
29856254
DOI:
10.1513/AnnalsATS.201803-197ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cyclic Nucleotide Phosphodiesterases, Type 5
Humans
Hypertension, Pulmonary*
Intention*
United States
Substances
Cyclic Nucleotide Phosphodiesterases, Type 5
Grants and funding
I01 BX002042/BX/BLRD VA/United States